甲基化修饰和免疫细胞透:在胃肠癌免疫治疗中针对催化子单元m-METTL复合物的影响
Chen Peng1, Fen Xiong1, Xi Pu2
1Department of Medical Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Frontiers in immunology
|January 8, 2024
概括
N6-甲基氨酸 (m6A) 甲基化调节RNA并影响胃肠癌的进展. 向m6A-METTL复合体 (MAC) 可能通过调节瘤免疫微环境来增强免疫治疗反应.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- N6-甲基氨酸 (m6A) 是一个关键的RNA修饰,调节细胞过程,如RNA稳定性,新陈代谢,拼接和翻译.
- 胃肠道 (GI) 癌症对全球健康构成重大负担.
- 包括METTL3/14在内的m6A-METTL复合体 (MAC) 涉及肠道癌的发展和进展.
研究的目的:
- 阐明MAC复合体在肠道癌症发病过程中的作用.
- 研究MAC对瘤免疫微环境 (TIME) 中免疫细胞透的影响.
- 探索向MAC的潜力,以提高肠道癌症的免疫疗法疗效.
主要方法:
- 对细胞过程中m6A修饰的新兴证据的审查.
- 分析METTL3/14在肠道癌的发展和进展中的作用.
- 检查时间内METTL3/14对免疫细胞透的m6A依赖调节.
- 评估向MAC的潜力,以增强对免疫检查点抑制剂 (ICI) 的反应.
主要成果:
- m6A 修饰对于调节各种细胞功能至关重要.
- MAC复合体 (METTL3/14) 在胃肠道癌的发展和进展中起着重要作用.
- METTL3/14以m6A-依赖的方式影响 TIME 中的免疫细胞透,影响癌细胞对 ICI 的反应.
结论:
- 了解MAC在肠道癌症发病过程中的作用及其对免疫细胞透的影响至关重要.
- 准METTL3/14及其下游基因可能是一个有希望的策略,以增强患者对肠道癌症免疫治疗的反应.
- 对MAC的进一步研究可能会为肠胃癌开启新的治疗策略.
关键词:
在METTL3/14中,我们可以使用METTL3或METTL4.N 6 - 甲基氨酸 (m 6 A) 的甲基化修饰.催化子单位 m 6 A-METTL复合体胃肠道的癌症,胃肠道的癌症.免疫细胞的透.免疫疗法 免疫疗法更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
